Physiological levels of melatonin contribute to the antioxidant capacity of human serum

Journal of Pineal Research

Volumn 27, Issue 1, 1999, Pages 59-64

  Benot, Soledad ^a   Goberna, Raimundo ^a   Reiter, Russel J ^b   Garcia Mauriño, Sofia ^a   Osuna, Carmen ^a   Guerrero, Juan M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; Antiaging; Circadian rhythm; Oxidative stress; Pineal gland

Indexed keywords

MELATONIN;

ADOLESCENT; ADULT; AGED; AGING; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CIRCADIAN RHYTHM; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; LIGHT DARK CYCLE; NORMAL HUMAN; SERUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; CIRCADIAN RHYTHM; DARKNESS; HUMANS; LIGHT; MELATONIN; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 0032773594     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1999.tb00597.x     Document Type: Article

References (42)

1. BARLOW-WALDEN, L.R., R.J. REITER, M. ABE, M. PABLOS, A. MENENDEZ-PELAEZ L.D. CHEN, B. POEGGELER (1996) Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 26:497-502.
2. BARTSCH, C., H. BARTSCH, U. FUCHS, T.H. LIPPERT, O. BELLMANN, D. GUPTA (1989) Stage-dependent depression of melatonin in patients with primary breast cancer: correlation with prolactin, thyroid stimulating hormone and steroid receptors. Cancer 64:426-433.
3. BENOT, S., P. MOLINERO, M. SOUTTO, R. GOBERNA, J.M. GUERRERO (1998) Circadian variations in the rat serum total antioxidant status: Correlation with melatonin levels. J. Pineal Res. 25:1-4.
4. BETTAHI, I., D. POZO, C. OSUNA, R.J. REITER, D. ACUNA-CASTROVIEJO, J.M. GUERRERO (1996) Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20:205-210.
5. 2 and cyclic AMP production in rat hypothalamus: A mechanism involving inhibition of nitric oxide synthase. J. Pineal Res. 25:34-40.
6. BRZEZINSKI, A. (1997) Melatonin in humans. N. Engl. J. Med. 336:186-195.
7. CUZZOCREA, S., B. ZINGARELLI, G. COSTANTINO, A.P. CAPUTI (1998) Protective effect of melatonin in non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25:24-33.
8. GARCIA-MAURIÑO, S., M.G. GONZALEZ-HABA, J.R. CALVO, M. RAFH-EL-IDRISSI, V. SANCHEZ-MARGALET, R. GOBERNA, J.M. GUERRERO (1997) Melatonin enhances IL-2, IL-6 and IFNgamma production by human circulating CD4+ cells: A possible nuclear receptor-mediated mechanism involving Th1 lymphocytes and monocytes. J. Immunol. 159:574-581.
9. GOLDMAN, B.O. (1983) The physiology of melatonin in mammals. Pineal Res. Rev. 1:145-182.
10. GUERRERO, J.M., R.J. REITER (1992) A brief survey of pineal gland-immune system interrelationships. Endocr. Res. 18:91-113.
11. HAIMOV, I., P. LAVIE, M. LAUDON, P. HERER, N. ZISAPEL (1995) Melatonin replacement therapy of elderly insomniacs. Sleep 18:598-603.
12. HILL, S.M., D.E. BLASK (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:6121-6126.
13. LEWY, A.J., S. AHMED, J.M. LATHAM-JACKSON, R.L. SACK (1992) Melatonin phase shifts human circadian rhythm according to a phase-response curve. Chronobiol. Int. 9:380392.
14. 2 • in the production of HO•: In vitro and in vivo. Free Radic. Biol. Med. 16:29-33.
15. MAESTRONI, G.J.M. (1993) The immunoendocrine role of melatonin. J. Pineal Res. 14:1-10.
16. MARSHALL, K.A., R.J. REITER, B. POEGGELER, O.I. ARUOMA, B. HALLIWELL (1996) Evaluation of the antioxidant activity of melatonin in vitro. Free Radic. Biol. Med. 21:307-315.
17. MEISTER, A. (1992) On the antioxidant effect of ascorbic acid and glutathione. Biochem. Pharmacol. 44:1905-1915.
18. MICHELET, F., R. GUEGUEN, P. LEKOY, M. WELLMAN, A. NICOLAS, G. SIEST (1995) Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables and life habits. Clin. Chem. 41:1509-1517.
19. MIGUEZ, J.M., J. RECIO, E. SANCHEZ-BARCELO, M. ALDEGUNDE (1998) Changes with age in daytime and nighttime contents of melatonin, indoleamines, and catecholamines in the pineal gland: A comparative study in rat and Syrian hamster. J. Pineal Res. 25:106-115.
20. PABLOS, M.I., J.M. GUERRERO, G.G. ORTIZ, M.I. AGAPITO, R.J. REITER (1997) Both melatonin and a putative nuclear melatonin receptor against CGP 52608 stimulate glutathione peroxidase and glutathione reductase in mouse brain in vivo. Neuroendocrinol. Lett. 18:49-58.
21. PACKER, L. (1994) Vitamin E is nature's master antioxidant. Sci. Am. (Sci. Med.) Mar Apr:54-63.
22. PALMER, R.M.J., D.S. ASHTON, S. MONCADA (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666.
23. PANZER, A., M. VILJOEN (1997) The validity of melatonin as an oncostatic agent. J. Pineal Res. 22:184-202.
24. PIERI, C., M. MARRA, F. MORONI, R. RECCIONI, F. MARCHESELLI (1994) Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:271-276.
25. POZO, D., R.J. REITER, J.R. CALVO, J.M. GUERRERO (1994) Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 55:PL455-PL460.
26. POZO, D., M. DELGADO, J.M. FERNANDEZ-SANTOS, J.R. CALVO, R.P. GOMARIZ, I. MARTIN-LACAVE, G.G. ORTIZ, J.M. GUERRERO (1997a) Expression of the membrane melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spicen. FASEB J. 11:466-473.
27. POZO, D, R.J. REITER, J.R. CALVO, J.M. GUERRERO (1997b) Inhibition of nitric oxide synthase and cyclic GMP production by physiological concentrations of melatonin in the rat cerebellum: A calmodulin-mediated mechanism. J. Cell. Biochem. 65:430-442.
28. 135I]iodomelatonin by rat spleen crude membranes: Day - night variations and effect of pinealectomy and continuous light exposure. J. Pineal Res. 20:33-38.
29. RAFH-EL-IDRISSI, M., J.R. CALVO, A. HARMOUCH, S. GARCIA-MAURIÑO, J.M. GUERRERO (1998) Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat. J. Neuroimmunol. 86:190-197.
30. REITER, R.J. (1986) Normal patterns of melatonin in the pineal gland and body fluids of human and experimental animals. J. Neural Transm. 21 (Suppl.):35-54.
31. REITER, R.J. (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:151-180.
32. REITER, R.J. (1992) The aging pineal gland and its physiological consequences. Bioessays 14:169-175.
33. REITER, R.J. (1995) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9:526-533.
34. REITER, R.J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:359-384.
35. REITER, R.J., D. MELCHIORRI, E. SEWERYNEK, B. POEGGELFR, L.R. BARLOW-WALDEN, J.I. CHUANG, G.G. ORTIZ, D. ACUN̄A-CASTROVIEJO (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
36. SACK, R.L., A.J. LEWY, D.I., ERB, W.M. VOLLNER, C.M. SINGER (1986) Human melatonin production decreases with age. J. Pineal Res. 3:319-328.
37. SCHMUCK, A., C.J. FULLER, S. DEVARAJ, I. JIALAL (1995) Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin. Chem. 41:1628-1632.
38. STASICA, P., P. ULANSKI, J.M. ROSIAK (1998) Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25:65-66.
39. SUSA, N., S. UENO, Y. FURUKAWA, J. UEDA, M. SUGIYAMA (1997) Potent protective effect of melatonin on chromium (VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144:377-384.
40. TAN, D.X., L.D. CHEN., B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993a) Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:57-160.
41. TAN, D.X., B. POEGGELER, R.J. REITER, L.D. CHEN, S. CHEN, L.C. MANCHESTER, L. BARLOW-WALDEN (1993b) The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:65-71.
42. TAN, D.X., R.J. REITER, L.D. CHEN, B. POEGGELER, L.C. MANCHESTER, L. BARLOW-WALDEN (1994) Both physiological and pharmacological levels of melatonin reduces DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215-218.